If you are having trouble viewing this e-mail, please click here

  Click here to visit our website                                                                                                                                      March 25, 2008

In this issue:

The new Framingham risk score AND beyond
Approaches to SHAPE the Future of Preventive Cardiology

Dr Valentin Fuster presents the SHAPE Award to Dr Dan Levy, Director of Framingham Heart Study and Dr Kwame Akosah, Professor of Internal Medicine at Univ of Virginia.

Program features the evolution of Framingham Risk Scoring and proposed multimodality approaches for CVD risk assessment. Moderators: Drs Blumenthal, Naghavi and Shah. Register now, space is limited. Online CME available

Register now: space is limited

 

q March's new slides in the PowerPoint Library

Predictive Value of Coronary Calcifications for Future Cardiac Events in Asymptomatic Individuals

Presented by:
Alexander Becker, MD, Alexander Leber, Christoph Becker, MD, Andreas Knez, MD

Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gating

Presented by:
Husmann L., Valenta I., Gaemperli O., Adda O., Treyer V., Wyss CA, Veit-Haibach P., Tatsugami F., von Schulthess GK, Kaufmann PA

Genome-wide Admixture Mapping for Coronary Artery Calcification in African Americans: The NHLBI Family Heart Study

Presented by:
Qunyuan Zhang, Cora E. Lewis, Lynne E. Wagenknecht, Richard H. Myers, James S. Pankow, Steven C. Hunt, Kari E. North, James E. Hixson, J. Jeffrey Carr, Lawrence C. Shimmin, Ingrid Borecki, Michael A. Province

Early treatment reduce the cardiovascular risk in newly diagnosed rheumatoid arthritis patients

Presented by:
AN Georgiadis, PV Voulgari, MI Argyropoulou, Y Alamanos, M Elisaf, AD Tselepis, AA Drosos

Difference in Carotid Intima-Media Thickness in Korean and Japanese men

Presented by:
J. Choo, H. Ueshima, Y. Jang, K. Sutton-Tyrrell, A. El-Saed, T. Kadowaki, T. Takamiya, T. Okamura, Y. Ueno, Y. Nakamura, A. Sekikawa, J. D. Curb, L.H. Kuller, & C. Shin

Prevalence and Clinical Predictors of Atherosclerotic CAD in Asymptomatic Patients Undergoing Coronary MDCT

Presented by:
Gil N. Bachar, MD, Ran Kornowski, MD, FACC,, MD, Shmuel Fuchs, MD, Eli Atar, MD

FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries

Presented by:
Bural G, Torigian DA, Chamroonrat W, Houseni M,Chen W, Basu S, Kumar R, Alavi A.

Automatic Plaque Characterization Employing Quantitative and Multi-contrast MRI

Presented by:

Binjian Sun, Don P. Giddens, Robert Long Jr., W. Robert Taylor, Diana Weiss, Giji Joseph, David Vega, John N. Oshinski

Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gating

Presented by:
Husmann L., Valenta I., Gaemperli O., Adda O., Treyer V., Wyss CA, Veit-Haibach P., Tatsugami F., von Schulthess GK, Kaufmann PA

Association between Cardiovascular Risk Profiles and the Presence and Extent of Different Types of Coronary Atherosclerotic Plaque as Detected by Multi-detector Computed Tomography

Presented by:
F. Bamberg, N. Dannemann, M. D. Shapiro, S. Seneviratne, M. Ferencik, J. Butler, W. Koenig, K. Nasir, R. C.Cury, A. Tawakol, S. Achenbach, T.J. Brady, and U. Hoffmann

Sex differences in the relation of HDL cholesterol to progression of carotid intima-media thickness: The Los Angeles Atherosclerosis Study

Presented by:
Amy Z. Fan, James H. Dwyer

A Negative Correlation between Human Carotid Atherosclerotic Plaque Progression and Plaque Wall Stress: In Vivo MRI-Based 2D/3D FSI Models

Presented by:
Dalin Tang, Chun Yang,  Sayan Mondal,  Fei Liu, Gador Canton, Thomas S. Hatsukami,  Chun Yuan

Turbulent blow flow plays an essential localizing role in the development of atherosclerotic lesions in experimentally-induced Hypercholesterolemia in rats

Presented by:
Prado CM, Ramos SG, Elias J Jr, Rossi MA


àSHAPE Symposium at ACC: March 29 from 4:00 to 6:00PM

àLatest Research: Uploaded in SHAPE's PPT library

Featured Links:

·    SHAPE Guideline
·    Downloads
·    PowerPoint Library

·    Newsletter Archive

Chairman
Morteza Naghavi, M.D

Board of Directors
Arthur Agatston, M.D.
Daniel Berman, M.D.
Matthew Budoff, M.D.
Erling Falk, MD, Ph.D.
Craig Hartley, Ph.D.
Harvey Hecht, M.D.
Roxana Mehran, M.D.
Ralph Metcalfe, Ph.D.
Joycelyn Ray, JD.
P.K. Shah, M.D.
Leslee Shaw, Ph.D.
JoAnne Zawitoski, Esq.

Board of Advisors
Juhani Airaksinen, M.D.
Dan E. Arking, M.D.
Juan Badimon, Ph.D
Roger Blumenthal, M.D.
Max A. Cameau, C.A.P.
Jay N. Cohn, M.D.
Ioannis Kakadiaris, Ph.D.
Sanjay Kaul, M.D.
Dan Keeney, A.P.R.
Wolfgang Koenig, MD, Ph.D.
Daniel Lane, MD, Ph.D.
Tasneem Z. Naqvi, M.D.

Director of Scientific Publications
Khurram Nasir, M.D.

Director of Public Relations
Paul Galloway

Director of Fundraising
Barbara S. Loggins

Mission:

To eradicate heart attack by championing new strategies for prevention while advancing the scientific quest for a cure.